Bruce Dunlevie - Jul 15, 2021 Form 4 Insider Report for 1Life Healthcare Inc (ONEM)

Role
Director
Signature
/s/ Ivy Tseng, Attorney-in-Fact for Bruce Dunlevie
Stock symbol
ONEM
Transactions as of
Jul 15, 2021
Transactions value $
$0
Form type
4
Date filed
7/19/2021, 06:49 PM
Previous filing
Jun 7, 2021
Next filing
Oct 19, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ONEM Common Stock Award $0 +534 $0.00 534 Jul 15, 2021 Direct F1
holding ONEM Common Stock 324K Jul 15, 2021 See footnote F2
holding ONEM Common Stock 7M Jul 15, 2021 See footnote F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units granted to the reporting person pursuant to the Issuer's 2020 Equity Incentive Plan. The restricted stock units vested immediately on the date of grant.
F2 Shares owned directly by entities controlled by Bruce W. Dunlevie.
F3 Shares are held directly by BCP V, as nominee for BCP V, Benchmark Founders' Fund V, L.P. ("BFF V"), Benchmark Founders' Fund V-A, L.P. ("BFF V-A"), Benchmark Founders' Fund V-B, L.P. ("BFF V-B") and related individuals. Benchmark Capital Management Co. V, L.L.C. ("BCMC V"), the general partner of BCP V, BFF V, BFF V-A and BFF V-B, may be deemed to have sole voting and dispositive power over the securities. Bruce W. Dunlevie, a member of the Issuer's board of directors, Alexandre Balkanski, Peter H. Fenton, J. William Gurley, Kevin R. Harvey, Robert C. Kagle, Mitchell H. Lasky and Steven M. Spurlock, the managing members of BCMC V, and each of them may be deemed to share voting and dispositive power over the securities held by such entities. Each such person and entity disclaims the existence of a "group" and disclaims beneficial ownership of the securities, except to the extent of such person's or entity's pecuniary interest in such securities.